Emvera Technologies, Inc.

Emvera Technologies, Inc. specializes in dermatological diode laser systems. These devices are primarily used for treatments like hair removal, skin rejuvenation, and addressing vascular lesions. The company’s portfolio includes models such as Emvera, Emvera, and EMVERA DIOLUX, all designed for controlled laser-based medical procedures.

Emvera Technologies, Inc. is based in the United States. As a US-based manufacturer, its devices fall under FDA jurisdiction. The company’s products are classified as Class II devices, which means they undergo regulatory review through the FDA’s 510(k) pathway and must comply with Unique Device Identification (UDI) requirements. This classification ensures these devices meet safety and effectiveness standards for their intended dermatological applications.

Emvera Technologies, Inc.’s devices are listed in the FDA’s 510(k) registry and the Unique Device Identification (UDI) system. These registries track Class II medical devices to ensure compliance with US regulatory standards. Listing in these systems confirms that the devices have undergone the necessary evaluations and meet requirements for market authorization in the US.

Emvera Technologies, Inc.’s devices are classified as Class II under FDA regulations. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and performance. Because of this classification, the company must submit a 510(k) premarket notification to demonstrate that its devices are substantially equivalent to legally marketed predicates. This process helps maintain high standards for dermatological laser systems.